# A Multicentre, Prospective, Non-interventional Trial Monitoring Therapy Pathways of Asthma Patients Treated With an Extra-fine ICS/LABA/LAMA Single-inhaler Triple Therapy in a Real-world Setting and Characterizing the Effects on Health-related Outcomes

> **NCT05728749** · — · UNKNOWN · sponsor: **Chiesi SAS** · enrollment: 300 (estimated)

## Conditions studied

- ASTHMA

## Interventions

- **OTHER:** Non-interventional

## Key facts

- **NCT ID:** NCT05728749
- **Lead sponsor:** Chiesi SAS
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-03
- **Primary completion:** 2024-03
- **Final completion:** 2025-03
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2023-07-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05728749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05728749, "A Multicentre, Prospective, Non-interventional Trial Monitoring Therapy Pathways of Asthma Patients Treated With an Extra-fine ICS/LABA/LAMA Single-inhaler Triple Therapy in a Real-world Setting and Characterizing the Effects on Health-related Outcomes". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05728749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*